Alkem MedTech to acquire 55% stake in Switzerland's Occlutech for €99.4M
Occlutech develops, manufactures, and commercialises medical devices for congenital heart disease, stroke prevention, and heart failure
Occlutech develops, manufactures, and commercialises medical devices for congenital heart disease, stroke prevention, and heart failure
The company reported profit before tax of Rs.67 crore, up sharply from Rs.21 crore in the same period last year
Anand Chemiceutics serves over 1,500 laboratories, hospitals, and government institutions
The revenues this quarter are in line with the outlook we envisaged for the year
Novo Medi Sciences aims to reach millions nationwide and provide NEXIPOX PLUS vaccination against chickenpox to thousands of underprivileged girl children
The Union Budget makes a clear and timely choice by placing biopharma at the centre of India’s next manufacturing wave
Subscribe To Our Newsletter & Stay Updated